Metabolic syndrome and homocysteine level as predictors of the severity of coronary artery disease in patients with carotid stenosis

American Journal of the Medical Sciences

Volumn 338, Issue 6, 2009, Pages 447-452

  Hsieh, Ming Jer ^a   Chen, Chun Chi ^a   Lee, Tsong Hai ^a   Lee, Cheng Hung ^a   Wen, Ming Shien ^a   Lin, Fun Chung ^a   Hsieh, I Chang ^a   Wu, Delon ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Carotid stenosis; Coronary artery disease; Homocysteine; Metabolic syndrome

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; BLOOD; MIDDLE AGED; RADIOGRAPHY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CAROTID STENOSIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 73949139115     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181ab1c96     Document Type: Article

References (41)

1. Chaturvedi S, Bruno A, Feasby T, et al. Carotid endarterectomy-an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2005;65:794-801.
2. Brott TG, Brown RD Jr, Meyer FB, et al. Carotid revascularization for prevention of stroke: carotid endarterectomy and carotid artery stenting. Mayo Clin Proc 2004;79:1197-1208
3. Groschel K, Knauth M, Ernemann U, et al. Early treatment after a symptomatic event is not associated with an increased risk of stroke in patients undergoing carotid stenting. Eur J Neurol 2008;15:2-5.
4. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97: 1837-1847
5. Veselka J, Cerna D, Zimolova P, et al. Thirty-day outcomes of direct carotid artery stenting with cerebral protection in high-risk patients. Circ J 2007;71:1468-1472
6. Arca M, Montali A, Valiante S, et al. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease. Am J Cardiol 2007;100: 1511-1516
7. Lemieux I, Lamarche B, Couillard C, et al. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med 2001;161:2685-2692
8. Mitsutake R, Miura S, Kawamura A, et al. Are metabolic factors associated with coronary artery stenosis on MDCT? Circ J 2009;73: 132-138
9. Paraskevas KI, Mikhailidis DP, Liapis CD. Internal carotid artery occlusion: association with atherosclerotic disease in other arterial beds and vascular risk factors. Angiology 2007;58:329-335
10. Yamashiro K, Watanabe T, Tanaka R, et al. Clustering of risk factors increases the incidence of echolucent carotid plaque in stroke patients. Cerebrovasc Dis 2006;22:432-438
11. Nygard O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-236 (Pubitemid 27310438)
12. Rasouli ML, Nasir K, Blumenthal RS, et al. Plasma homocysteine predicts progression of atherosclerosis. Atherosclerosis 2005;181: 159-165
13. Solymoss BC, Bourassa MG, Campeau L, et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004;93:159-164
14. Wassink AM, van der Graaf Y, Olijhoek JK, et al. Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2008; 29:213-223
15. Hoshino A, Nakamura T, Enomoto S, et al. Prevalence of coronary artery disease in Japanese patients with cerebral infarction: impact of metabolic syndrome and intracranial large artery atherosclerosis. Circ J 2008;72:404-408
16. Bates ER, Babb JD, Casey DE Jr, et al. ACCF/SCAI/SVMB/SIR/ ASITN 2007 Clinical Expert Consensus Document on carotid stenting. Vasc Med 2007;12:35-83.
17. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470
18. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991;325:445-453
19. Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 1990;119: 1262-1267
20. Bozkurt E, Keles S, Acikel M, et al. Plasma homocysteine level and the angiographic extent of coronary artery disease. Angiology 2004;55: 265-270
21. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990;21: 637-676
22. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
23. Hofmann R, Kypta A, Steinwender C, et al. Mid-term outcome after carotid artery stenting depends on presence of coronary artery disease. Ann Med 2006;38:137-143
24. Hofmann R, Kypta A, Steinwender C, et al. Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease. Heart 2005;91:1438-1441
25. Wu YW, Lin MS, Lin YH, et al. Prevalence of concomitant atherosclerotic arterial diseases in patients with significant cervical carotid artery stenosis in Taiwan. Int J Cardiovasc Imaging 2007;23:433-439
26. Montalescot G, Ankri A, Chadefaux-Vekemans B, et al. Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease. Int J Cardiol 1997;60:295-300.
27. Ambrosetti M, Pedretti RF. Does metabolic syndrome predict silent carotid stenosis in coronary patients? Intern Emerg Med 2008;3:81-82
28. VanderLaan PA, Reardon CA, Getz GS. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol 2004;24:12-22.
29. Wilson PW, Hoeg JM, D'Agostino RB, et al. Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. N Engl J Med 1997;337:516-522
30. Gorter PM, Olijhoek JK, van der Graaf Y, et al. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis 2004;173:363-369 (Pubitemid 38469808)
31. Lind L. Endothelium-dependent vasodilation, insulin resistance and the metabolic syndrome in an elderly cohort: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Atherosclerosis 2008;196:795-802.
32. Neunteufl T, Katzenschlager R, Hassan A, et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 1997;129:111-118
33. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-128
34. Iso H, Moriyama Y, Sato S, et al. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation 2004;109:2766-2772
35. Shimizu H, Kiyohara Y, Kato I, et al. Plasma homocyst(e) ine concentrations and the risk of subtypes of cerebral infarction. The Hisayama study. Cerebrovasc Dis 2002;13:9-15.
36. Adachi H, Hirai Y, Fujiura Y, et al. Plasma homocysteine levels and atherosclerosis in Japan: epidemiological study by use of carotid ultrasonography. Stroke 2002;33:2177-2181
37. B-Vitamin Treatment Trialists' Collaboration. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J 2006;151:282-287
38. Martin-Herrero F, Jimenez-Candil J, Martin-Moreiras J, et al. Homocysteine, cause or consequence? Int J Cardiol 2008;129: 276-277
39. Mikael LG, Genest J Jr, Rozen R. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ Res 2006;98:564-571
40. Obeid R, Herrmann W. Homocysteine and lipids: S-adenosyl methionine as a key intermediate. FEBS Lett 2009;583:1215-1225
41. Mikael LG, Rozen R. Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-kappaB/iNOS. Cardiovasc Res 2008;80:151-158